Nedimesken (Talk | contribs) |
Nedimesken (Talk | contribs) |
||
Line 84: | Line 84: | ||
<div class="col-md-6" style="text-align:center"> | <div class="col-md-6" style="text-align:center"> | ||
<img width="700" src="https://static.igem.org/mediawiki/2018/c/c1/T--METU_HS_Ankara--res02.jpg" /> | <img width="700" src="https://static.igem.org/mediawiki/2018/c/c1/T--METU_HS_Ankara--res02.jpg" /> | ||
− | + | <div style="clear:both"></div> | |
<i class="parts-info"> | <i class="parts-info"> | ||
Figure 2: Plate image showing basic part 2 (GSH) transformed into DH5α colonies we’ve obtained.The medium was LB with Chl 40. | Figure 2: Plate image showing basic part 2 (GSH) transformed into DH5α colonies we’ve obtained.The medium was LB with Chl 40. | ||
Line 99: | Line 99: | ||
<div class="col-md-12" style="text-align:center"> | <div class="col-md-12" style="text-align:center"> | ||
<img width="700" src="https://static.igem.org/mediawiki/2018/d/d0/T--METU_HS_Ankara--res03.jpg" /> | <img width="700" src="https://static.igem.org/mediawiki/2018/d/d0/T--METU_HS_Ankara--res03.jpg" /> | ||
− | + | <div style="clear:both"></div> | |
<i class="parts-info"> | <i class="parts-info"> | ||
Figure 3: Gel image of the PCR confirmation of basic part 1 (FucO) insertion into pSB1C3. | Figure 3: Gel image of the PCR confirmation of basic part 1 (FucO) insertion into pSB1C3. | ||
Line 106: | Line 106: | ||
<h3>Basic part 2 (GSH) in pSB1C3 (<a href="http://parts.igem.org/Part:BBa_K2571001">BBa_K2571001</a>) PCR Confirmation:</h3> | <h3>Basic part 2 (GSH) in pSB1C3 (<a href="http://parts.igem.org/Part:BBa_K2571001">BBa_K2571001</a>) PCR Confirmation:</h3> | ||
− | + | ||
<p> | <p> | ||
10th well in the gel image below, which belongs to the 8th colony from basic 2 (GSH) cloned DH5α, proves our insertion and transformation right. We’ve used | 10th well in the gel image below, which belongs to the 8th colony from basic 2 (GSH) cloned DH5α, proves our insertion and transformation right. We’ve used | ||
Line 114: | Line 114: | ||
<div class="col-md-12" style="text-align:center"> | <div class="col-md-12" style="text-align:center"> | ||
<img width="700" src="https://static.igem.org/mediawiki/2018/6/6e/T--METU_HS_Ankara--bparts04.jpg" /> | <img width="700" src="https://static.igem.org/mediawiki/2018/6/6e/T--METU_HS_Ankara--bparts04.jpg" /> | ||
− | + | <div style="clear:both"></div> | |
<i class="parts-info"> | <i class="parts-info"> | ||
Figure 4: Gel image of the PCR confirmation of basic part 2 (GSH) insertion into pSB1C3. | Figure 4: Gel image of the PCR confirmation of basic part 2 (GSH) insertion into pSB1C3. | ||
Line 161: | Line 161: | ||
<div class="col-md-12" style="text-align:center"> | <div class="col-md-12" style="text-align:center"> | ||
<img width="700" src="https://static.igem.org/mediawiki/2018/f/f1/T--METU_HS_Ankara--cparts07.jpg" /> | <img width="700" src="https://static.igem.org/mediawiki/2018/f/f1/T--METU_HS_Ankara--cparts07.jpg" /> | ||
− | + | <div style="clear:both"></div> | |
<i class="parts-info"> | <i class="parts-info"> | ||
Figure 8: Gel image of the PCR confirmation of composite part 1 (FucO) insertion into pSB1C3 | Figure 8: Gel image of the PCR confirmation of composite part 1 (FucO) insertion into pSB1C3 | ||
Line 177: | Line 177: | ||
<div class="col-md-12" style="text-align:center"> | <div class="col-md-12" style="text-align:center"> | ||
<img width="700" src="https://static.igem.org/mediawiki/2018/9/9d/T--METU_HS_Ankara--cparts01256eeie6.jpg" /> | <img width="700" src="https://static.igem.org/mediawiki/2018/9/9d/T--METU_HS_Ankara--cparts01256eeie6.jpg" /> | ||
− | + | <div style="clear:both"></div> | |
<i class="parts-info"> | <i class="parts-info"> | ||
Figure 9: Gel image of the PCR confirmation of composite part 2 (GSH) insertion into pSB1C3. | Figure 9: Gel image of the PCR confirmation of composite part 2 (GSH) insertion into pSB1C3. | ||
Line 196: | Line 196: | ||
<div class="col-md-12" style="text-align:center"> | <div class="col-md-12" style="text-align:center"> | ||
<img width="700" src="https://static.igem.org/mediawiki/2018/4/45/T--METU_HS_Ankara--res10.jpg" /> | <img width="700" src="https://static.igem.org/mediawiki/2018/4/45/T--METU_HS_Ankara--res10.jpg" /> | ||
− | + | <div style="clear:both"></div> | |
<i class="parts-info"> | <i class="parts-info"> | ||
Figure 10: Gel image of the PCR confirmation of composite part 3 (dual expression of FucO and GSH) insertion into pSB1C3. | Figure 10: Gel image of the PCR confirmation of composite part 3 (dual expression of FucO and GSH) insertion into pSB1C3. | ||
Line 219: | Line 219: | ||
<div class="col-md-12" style="text-align:center"> | <div class="col-md-12" style="text-align:center"> | ||
<img src="https://static.igem.org/mediawiki/2018/1/1a/T--METU_HS_Ankara--res11.jpg" /> | <img src="https://static.igem.org/mediawiki/2018/1/1a/T--METU_HS_Ankara--res11.jpg" /> | ||
− | + | <div style="clear:both"></div> | |
<i class="parts-info"> | <i class="parts-info"> | ||
Figure 11: Plate image showing composite part 1 (FucO) and composite part 2 (GSH) transformed into KO11. The medium was LB with Chl 150 and Amp 100. | Figure 11: Plate image showing composite part 1 (FucO) and composite part 2 (GSH) transformed into KO11. The medium was LB with Chl 150 and Amp 100. | ||
Line 227: | Line 227: | ||
<div class="col-md-12" style="text-align:center"> | <div class="col-md-12" style="text-align:center"> | ||
<img src="https://static.igem.org/mediawiki/2018/f/f2/T--METU_HS_Ankara--res12.jpg" /> | <img src="https://static.igem.org/mediawiki/2018/f/f2/T--METU_HS_Ankara--res12.jpg" /> | ||
− | + | <div style="clear:both"></div> | |
<i class="parts-info"> | <i class="parts-info"> | ||
Figure 12: Plate image showing composite part 3 (FucO and GSH together) transformed into KO11.The medium was LB with Chl 150 and Amp 100. | Figure 12: Plate image showing composite part 3 (FucO and GSH together) transformed into KO11.The medium was LB with Chl 150 and Amp 100. | ||
Line 242: | Line 242: | ||
<div class="col-md-12" style="text-align:center"> | <div class="col-md-12" style="text-align:center"> | ||
<img src="https://static.igem.org/mediawiki/2018/f/f1/T--METU_HS_Ankara--cparts07.jpg" /> | <img src="https://static.igem.org/mediawiki/2018/f/f1/T--METU_HS_Ankara--cparts07.jpg" /> | ||
− | + | <div style="clear:both"></div> | |
<i class="parts-info"> | <i class="parts-info"> | ||
Figure 13: Gel image of the PCR confirmation of composite part 1 (FucO) insertion into pSB1A3. | Figure 13: Gel image of the PCR confirmation of composite part 1 (FucO) insertion into pSB1A3. | ||
Line 257: | Line 257: | ||
<div class="col-md-12" style="text-align:center"> | <div class="col-md-12" style="text-align:center"> | ||
<img src="https://static.igem.org/mediawiki/2018/0/00/T--METU_HS_Ankara--res14.jpg" /> | <img src="https://static.igem.org/mediawiki/2018/0/00/T--METU_HS_Ankara--res14.jpg" /> | ||
− | + | <div style="clear:both"></div> | |
<i class="parts-info"> | <i class="parts-info"> | ||
Figure 14: Gel image of the PCR confirmation of composite part 2 (GSH) insertion into pSB1A3. | Figure 14: Gel image of the PCR confirmation of composite part 2 (GSH) insertion into pSB1A3. | ||
Line 273: | Line 273: | ||
<div class="col-md-12" style="text-align:center"> | <div class="col-md-12" style="text-align:center"> | ||
<img src="https://static.igem.org/mediawiki/2018/4/45/T--METU_HS_Ankara--res10.jpg" /> | <img src="https://static.igem.org/mediawiki/2018/4/45/T--METU_HS_Ankara--res10.jpg" /> | ||
− | + | <div style="clear:both"></div> | |
<i class="parts-info"> | <i class="parts-info"> | ||
Figure 15: Gel image of the PCR confirmation of composite part 3 (dual expression of FucO and GSH) into pSB1A3. | Figure 15: Gel image of the PCR confirmation of composite part 3 (dual expression of FucO and GSH) into pSB1A3. | ||
Line 302: | Line 302: | ||
<div class="col-md-12" style="text-align:center"> | <div class="col-md-12" style="text-align:center"> | ||
<img style="width: 100%; height: 100%;"src="https://static.igem.org/mediawiki/2018/9/90/T--METU_HS_Ankara--assay01.jpg" /> | <img style="width: 100%; height: 100%;"src="https://static.igem.org/mediawiki/2018/9/90/T--METU_HS_Ankara--assay01.jpg" /> | ||
− | + | <div style="clear:both"></div> | |
<i class="parts-info"> | <i class="parts-info"> | ||
Figure 16: Representation of our biochemical assay #1 | Figure 16: Representation of our biochemical assay #1 | ||
Line 369: | Line 369: | ||
<div class="col-md-12" style="text-align:center"> | <div class="col-md-12" style="text-align:center"> | ||
<img style="width: 70%; height: 70%;"src="https://static.igem.org/mediawiki/parts/c/c2/METU_HS_Ankara_biochemical_assay_results.jpg"> | <img style="width: 70%; height: 70%;"src="https://static.igem.org/mediawiki/parts/c/c2/METU_HS_Ankara_biochemical_assay_results.jpg"> | ||
− | + | <div style="clear:both"></div> | |
<i class="parts-info"> | <i class="parts-info"> | ||
Figure 17: Graph showing cell growth of assay groups with respect to time. | Figure 17: Graph showing cell growth of assay groups with respect to time. |
Revision as of 17:04, 16 October 2018